December 2, 2021
The Weill Cornell Medicine SPORE in Prostate Cancer is proud to announce the newly awarded recepients for DRP sponsored projects. These investigators will each recieve seed funding for innovative translational research pilot projects that address key challenge areas in prostate cancer research.
By funding research from its inception, we are able to develop the careers of early stage and experienced investigators committed to prostate cancer. With the innovation of these investigators, the SPORE will establish new approaches to treating prostate cancer, which will result in improved patient survival and quality of life.
For more information and details on the new DRP projects please visit this LINK.